To invest up to $500 million in the US healthcare IT product and platform firms
Shiv Nadar and Sanjay Kalra have launched Shiv Nadar & Sanjay Kalra Associates (SNSK), an investment firm. The firm will focus on healthcare technology investments in the US. Reportedly, SNSK will invest up to $500 million to buy-out IT product and platform companies across providers, payers, pharma and life sciences, which are either disrupting or being disrupted by the confluence of regulatory changes, evolving consumer attitudes, changing demographics and emerging technologies.
SNSK’s investment thesis favours creating an integrated portfolio of mature businesses. The firm will also invest in select early stage US and Indian companies, where product, platform or talent will accelerate portfolio objectives. The focus areas include hospitals, ambulatory, long term acute care, physician practice, information exchanges, ACOs, self-funded and commercial insurers as well as insurance exchanges.
Shiv Nadar, Chairman, HCL and Mentor, SNSK, said, “Over the next five years, SNSK aspires to be an engine of accelerating digital solutions that would make patient care more accountable, efficient, predictable and effective. I am delighted to join hands with Sanjay and Mahesh in this exciting journey.”
Sanjay Kalra, SNSK Chairman said, “We will support management teams to unlock value in their companies through our entrepreneurial passion, engineering heritage and global operating experience.”
Mahesh Nagaraj, MD, SNSK added, “The firm intends to realise synergies across its portfolio and rigorously explore growth in new markets. SNSK’s operational expertise, cost discipline, India based R&D capability and cutting-edge technology adoption will support businesses in achieving their potential.”
EH News Bureau